ResearcherWest Virginia UniversityNo recent work listed

Jeffrey M. Ryckman

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1092-7021; OpenAlex author ID A5069241066. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2021: 1 paper

Papers 1

The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is it time for change? Co-author DOI 10.1016/j.ctro.2021.04.002 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

William Adrian Hall · 1 shared paper, 2021 · strength 0.15
- Paper The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is… DOI 10.1016/j.ctro.2021.04.002 ↗
Bradley Norman Reames · 1 shared paper, 2021 · strength 0.15
- Paper The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is… DOI 10.1016/j.ctro.2021.04.002 ↗
Chi H. Lin · 1 shared paper, 2021 · strength 0.15
- Paper The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is… DOI 10.1016/j.ctro.2021.04.002 ↗
Michael J. Baine · 1 shared paper, 2021 · strength 0.15
- Paper The timing and design of stereotactic radiotherapy approaches as a part of neoadjuvant therapy in pancreatic cancer: Is… DOI 10.1016/j.ctro.2021.04.002 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.